$OPRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in OptimizeRx Corp.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in OptimizeRx Corp. Get notifications about new insider transactions in OptimizeRx Corp for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 02 2021	OPRX	OptimizeRx Corp	WASSON GREGORY D	Director	Grant	A	0.00	539	0	17,524	17 K to 17.5 K (+3.17 %)
Apr 02 2021	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Grant	A	0.00	539	0	32,483	31.9 K to 32.5 K (+1.69 %)
Apr 02 2021	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Grant	A	0.00	539	0	21,928	21.4 K to 21.9 K (+2.52 %)
Apr 02 2021	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	539	0	32,253	31.7 K to 32.3 K (+1.70 %)
Apr 02 2021	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	539	0	64,421	63.9 K to 64.4 K (+0.84 %)
Mar 26 2021	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	M	3.21	394,739	1,267,112	0
Mar 26 2021	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Payment of Exercise	F	47.44	26,710	1,267,122	561,307	588 K to 561.3 K (-4.54 %)
Mar 26 2021	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	M	3.21	394,739	1,267,112	588,017	193.3 K to 588 K (+204.23 %)
Mar 26 2021	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Sell	S	46.10	80,000	3,688,000	193,278	273.3 K to 193.3 K (-29.27 %)
Mar 26 2021	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Sell	S	50.50	20,000	1,010,000	273,278	293.3 K to 273.3 K (-6.82 %)
Jan 29 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	7.51	4,315	32,406	107,134
Jan 29 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	7.51	4,315	32,406	90,217	85.9 K to 90.2 K (+5.02 %)
Jan 29 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	47.25	5,032	237,762	85,902	90.9 K to 85.9 K (-5.53 %)
Jan 29 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	7.51	4,315	32,406	107,134
Jan 29 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	7.51	4,315	32,406	90,217	85.9 K to 90.2 K (+5.02 %)
Jan 29 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	47.25	5,032	237,762	85,902	90.9 K to 85.9 K (-5.53 %)
Jan 20 2021	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	802	0	31,714	30.9 K to 31.7 K (+2.59 %)
Jan 20 2021	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	1,183	0	30,912	29.7 K to 30.9 K (+3.98 %)
Jan 15 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	7.51	5,000	37,550	96,993
Jan 15 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	7.51	5,000	37,550	90,937	85.9 K to 90.9 K (+5.82 %)
Jan 15 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	7.51	5,000	37,550	96,993
Jan 15 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	38.89	5,000	194,450	85,937	90.9 K to 85.9 K (-5.50 %)
Jan 15 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	7.51	5,000	37,550	90,937	85.9 K to 90.9 K (+5.82 %)
Jan 15 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	38.89	5,000	194,450	85,937	90.9 K to 85.9 K (-5.50 %)
Jan 11 2021	OPRX	OptimizeRx Corp	Silvestro Stephen L	CHIEF COMMERCIAL OF ...	Option Exercise	A	37.50	38,511	1,444,163	144,444
Jan 11 2021	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Option Exercise	A	37.50	24,093	903,488	254,318
Jan 11 2021	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	A	0.00	28,883	0	28,883
Jan 11 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	A	37.50	14,456	542,100	116,449
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	7.51	4,000	30,040	101,993
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	4,566	11,232	105,993
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	7.51	4,000	30,040	90,937	86.9 K to 90.9 K (+4.60 %)
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	7.51	4,000	30,040	101,993
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	4,566	11,232	86,937	82.4 K to 86.9 K (+5.54 %)
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	4,566	11,232	105,993
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	32.88	8,334	274,022	82,371	90.7 K to 82.4 K (-9.19 %)
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	7.51	4,000	30,040	90,937	86.9 K to 90.9 K (+4.60 %)
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	4,566	11,232	86,937	82.4 K to 86.9 K (+5.54 %)
Jan 05 2021	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	32.88	8,334	274,022	82,371	90.7 K to 82.4 K (-9.19 %)
Jan 05 2021	OPRX	OptimizeRx Corp	WASSON GREGORY D	Director	Grant	A	0.00	802	0	16,985	16.2 K to 17 K (+4.96 %)
Jan 05 2021	OPRX	OptimizeRx Corp	WASSON GREGORY D	Director	Grant	A	0.00	1,183	0	16,183	15 K to 16.2 K (+7.89 %)
Jan 05 2021	OPRX	OptimizeRx Corp	WASSON GREGORY D	Director	Grant	A	0.00	802	0	16,985	16.2 K to 17 K (+4.96 %)
Jan 05 2021	OPRX	OptimizeRx Corp	WASSON GREGORY D	Director	Grant	A	0.00	1,183	0	16,183	15 K to 16.2 K (+7.89 %)
Nov 13 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	15,000	36,900	110,559
Nov 13 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	15,000	36,900	90,705	75.7 K to 90.7 K (+19.81 %)
Nov 13 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	24.05	15,000	360,750	75,705	90.7 K to 75.7 K (-16.54 %)
Sep 04 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	10,000	24,600	125,559
Sep 04 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	10,000	24,600	90,705	80.7 K to 90.7 K (+12.39 %)
Sep 04 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	20.00	10,000	200,000	80,705	90.7 K to 80.7 K (-11.02 %)
Sep 04 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	10,000	24,600	125,559
Sep 04 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	10,000	24,600	90,705	80.7 K to 90.7 K (+12.39 %)
Sep 04 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	20.00	10,000	200,000	80,705	90.7 K to 80.7 K (-11.02 %)
Aug 14 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	10,000	24,600	135,559
Aug 14 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	10,000	24,600	110,671	100.7 K to 110.7 K (+9.93 %)
Aug 14 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	18.00	10,000	180,000	100,671	110.7 K to 100.7 K (-9.04 %)
Aug 11 2020	OPRX	OptimizeRx Corp	WASSON GREGORY D	Director	Buy	P	17.49	15,000	262,350	15,000	0 to 15 K
Aug 07 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	10,000	24,600	145,559
Aug 07 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	10,000	24,600	110,671	100.7 K to 110.7 K (+9.93 %)
Aug 07 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	17.01	10,000	170,100	100,671	110.7 K to 100.7 K (-9.04 %)
Jul 17 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	2.46	8,000	19,680	155,559
Jul 17 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	2.46	8,000	19,680	90,671	82.7 K to 90.7 K (+9.68 %)
Jul 17 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	15.00	6,667	100,005	82,671	89.3 K to 82.7 K (-7.46 %)
Jul 02 2020	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	1,937	0	29,729	27.8 K to 29.7 K (+6.97 %)
Jul 02 2020	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	1,937	0	61,897	60 K to 61.9 K (+3.23 %)
Jul 02 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	M	0.00	21,187	0	42,372
Jul 02 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	M	0.00	21,187	0	229,719	208.5 K to 229.7 K (+10.16 %)
Jun 26 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	M	3.21	45,261	145,288	394,739
Jun 26 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	M	3.21	45,261	145,288	208,528	163.3 K to 208.5 K (+27.72 %)
Apr 01 2020	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	8.75	1,000	8,750	28,022	27 K to 28 K (+3.70 %)
Mar 31 2020	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Grant	A	0.00	2,784	0	17,467	14.7 K to 17.5 K (+18.96 %)
Mar 31 2020	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	2,784	0	59,960	57.2 K to 60 K (+4.87 %)
Mar 31 2020	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Grant	A	0.00	2,784	0	27,022	24.2 K to 27 K (+11.49 %)
Mar 31 2020	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	2,784	0	27,792	25 K to 27.8 K (+11.13 %)
Mar 13 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	A	0.00	84,746	0	84,746
Mar 13 2020	OPRX	OptimizeRx Corp	Silvestro Stephen L	CHIEF COMMERCIAL OF ...	Option Exercise	A	7.51	105,933	795,557	105,933
Mar 13 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	A	7.51	63,558	477,321	186,861
Mar 13 2020	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Option Exercise	A	7.51	63,558	477,321	230,225
Mar 05 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	M	3.21	30,000	96,300	440,000
Mar 05 2020	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	M	3.21	30,000	96,300	163,267	133.3 K to 163.3 K (+22.51 %)
Jan 30 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	Chief Financial Off ...	Option Exercise	M	3.15	5,032	15,851	123,303
Jan 30 2020	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	Chief Financial Off ...	Buy	M	3.15	5,032	15,851	71,917	66.9 K to 71.9 K (+7.52 %)
Jan 07 2020	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Grant	A	0.00	2,084	0	24,238	22.2 K to 24.2 K (+9.41 %)
Jan 07 2020	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Grant	A	0.00	2,084	0	14,683	12.6 K to 14.7 K (+16.54 %)
Jan 07 2020	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	2,084	0	25,008	22.9 K to 25 K (+9.09 %)
Jan 07 2020	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	2,084	0	57,176	55.1 K to 57.2 K (+3.78 %)
Dec 05 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	M	3.21	30,000	96,300	470,000
Dec 05 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	M	3.21	30,000	96,300	133,267	103.3 K to 133.3 K (+29.05 %)
Nov 14 2019	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	9.62	600	5,772	22,154	21.6 K to 22.2 K (+2.78 %)
Nov 13 2019	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Buy	P	9.80	5,000	49,000	55,092	50.1 K to 55.1 K (+9.98 %)
Nov 07 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	Chief Financial Off ...	Option Exercise	M	3.15	5,000	15,750	128,335
Nov 07 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	Chief Financial Off ...	Buy	M	3.15	5,000	15,750	66,885	61.9 K to 66.9 K (+8.08 %)
Nov 06 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	P	9.50	5,000	47,500	103,267	98.3 K to 103.3 K (+5.09 %)
Oct 02 2019	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Grant	A	0.00	2,084	0	21,554	19.5 K to 21.6 K (+10.70 %)
Oct 02 2019	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Grant	A	0.00	2,084	0	12,599	10.5 K to 12.6 K (+19.82 %)
Oct 02 2019	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	2,084	0	22,924	20.8 K to 22.9 K (+10.00 %)
Oct 02 2019	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	2,084	0	50,092	48 K to 50.1 K (+4.34 %)
May 13 2019	OPRX	OptimizeRx Corp	AWM Investment Company, Inc.	10% Owner	Sell	S	13.72	7,126	97,744	1,264,402	1.3 M to 1.3 M (-0.56 %)
May 13 2019	OPRX	OptimizeRx Corp	AWM Investment Company, Inc.	10% Owner	Sell	S	13.76	25,000	343,885	1,271,528	1.3 M to 1.3 M (-1.93 %)
May 13 2019	OPRX	OptimizeRx Corp	AWM Investment Company, Inc.	10% Owner	Sell	S	13.57	50,000	678,595	1,296,528	1.3 M to 1.3 M (-3.71 %)
May 13 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	3.15	8,334	26,252	0
May 13 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	3.15	8,334	26,252	61,885	53.6 K to 61.9 K (+15.56 %)
May 03 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	3.15	5,000	15,750	8,334
May 03 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	3.15	5,000	15,750	53,551	48.6 K to 53.6 K (+10.30 %)
May 03 2019	OPRX	OptimizeRx Corp	Silvestro Stephen L	CHIEF COMMERCIAL OF ...	Option Exercise	A	0.00	90,000	0	90,000
Mar 29 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	C	0.00	16,667	0	10,000
Mar 29 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Grant	A	0.00	16,667	0	48,551	31.9 K to 48.6 K (+52.27 %)
Mar 29 2019	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Grant	A	0.00	2,084	0	17,386	15.3 K to 17.4 K (+13.62 %)
Mar 29 2019	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	2,084	0	14,585	12.5 K to 14.6 K (+16.67 %)
Mar 29 2019	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	2,084	0	48,008	45.9 K to 48 K (+4.54 %)
Mar 29 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	C	0.00	80,000	0	30,000
Mar 29 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Grant	A	0.00	80,000	0	98,267	18.3 K to 98.3 K (+437.95 %)
Mar 29 2019	OPRX	OptimizeRx Corp	Paramore Miriam J	RESIDENT	Option Exercise	C	0.00	16,667	0	10,000
Mar 29 2019	OPRX	OptimizeRx Corp	Paramore Miriam J	RESIDENT	Grant	A	0.00	16,667	0	24,079	7.4 K to 24.1 K (+224.87 %)
Mar 29 2019	OPRX	OptimizeRx Corp	Hamilton Terrence	SVP OF SALES	Option Exercise	C	0.00	16,667	0	133,333
Mar 29 2019	OPRX	OptimizeRx Corp	Hamilton Terrence	SVP OF SALES	Grant	A	0.00	16,667	0	141,471	124.8 K to 141.5 K (+13.35 %)
Mar 19 2019	OPRX	OptimizeRx Corp	AWM Investment Company, Inc.	10% Owner	Sell	S	15.15	7,760	117,553	1,346,528	1.4 M to 1.3 M (-0.57 %)
Mar 19 2019	OPRX	OptimizeRx Corp	AWM Investment Company, Inc.	10% Owner	Sell	S	15.00	13,637	204,555	1,354,288	1.4 M to 1.4 M (-1.00 %)
Feb 26 2019	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Option Exercise	A	0.00	10,000	0	26,667
Feb 26 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	A	0.00	30,000	0	110,000
Feb 26 2019	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Option Exercise	J	1.07	100,000	107,000	500,000
Feb 26 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	A	0.00	10,000	0	26,667
Jan 03 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	3.15	5,000	15,750	13,334
Jan 03 2019	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	3.15	5,000	15,750	31,884	26.9 K to 31.9 K (+18.60 %)
Dec 20 2018	OPRX	OptimizeRx Corp	WPP plc	10% Owner	Sell	S	0.00	2,103,702	0	0	2.1 M to 0 (-100.00 %)
Dec 20 2018	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Buy	P	9.85	1,015	9,998	7,412	6.4 K to 7.4 K (+15.87 %)
Dec 20 2018	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	P	9.94	2,000	19,880	18,267	16.3 K to 18.3 K (+12.29 %)
Nov 20 2018	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	14.30	3,000	42,900	45,924	42.9 K to 45.9 K (+6.99 %)
Nov 08 2018	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	P	16.32	600	9,792	16,267	15.7 K to 16.3 K (+3.83 %)
Oct 12 2018	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	2,084	0	12,501	10.4 K to 12.5 K (+20.01 %)
Oct 10 2018	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	0.00	2,084	0	15,302	13.2 K to 15.3 K (+15.77 %)
Oct 10 2018	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Buy	P	0.00	2,084	0	4,263	2.2 K to 4.3 K (+95.64 %)
Oct 10 2018	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	2,084	0	42,924	40.8 K to 42.9 K (+5.10 %)
Aug 10 2018	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Option Exercise	M	3.15	15,000	47,250	151,669
Aug 10 2018	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Buy	M	3.15	15,000	47,250	26,884	11.9 K to 26.9 K (+126.22 %)
Aug 10 2018	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	12.05	1,000	12,050	11,884	12.9 K to 11.9 K (-7.76 %)
Aug 10 2018	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	12.01	1,000	12,010	12,884	13.9 K to 12.9 K (-7.20 %)
Aug 10 2018	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	12.00	2,000	24,000	13,884	15.9 K to 13.9 K (-12.59 %)
Aug 10 2018	OPRX	OptimizeRx Corp	BAKER DOUGLAS P	CHIEF FINANCIAL OFF ...	Sell	S	12.00	784	9,408	15,884	16.7 K to 15.9 K (-4.70 %)
Jul 03 2018	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	0.00	2,084	0	13,218	11.1 K to 13.2 K (+18.72 %)
Jul 03 2018	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Buy	P	0.00	2,084	0	2,179	95 to 2.2 K (+2,193.68 %)
Jul 03 2018	OPRX	OptimizeRx Corp	Lang James Paul	Director	Grant	A	0.00	2,084	0	10,417	8.3 K to 10.4 K (+25.01 %)
Jul 03 2018	OPRX	OptimizeRx Corp	HALAS GUS D	Director	Grant	A	0.00	2,084	0	40,840	38.8 K to 40.8 K (+5.38 %)
Jun 28 2018	OPRX	OptimizeRx Corp	Spangler Patrick D	Director	Buy	P	9.95	95	945	95	0 to 95
Jun 27 2018	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	10.72	250	2,680	11,134	10.9 K to 11.1 K (+2.30 %)
Jun 27 2018	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	10.47	1,100	11,517	10,884	9.8 K to 10.9 K (+11.24 %)
Jun 27 2018	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	10.29	50	515	9,784	9.7 K to 9.8 K (+0.51 %)
Jun 27 2018	OPRX	OptimizeRx Corp	Vos Ellen O'Connor	Director	Buy	P	10.35	400	4,140	9,734	9.3 K to 9.7 K (+4.29 %)
Jun 26 2018	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Buy	P	10.50	100	1,050	6,397	6.3 K to 6.4 K (+1.59 %)
Jun 25 2018	OPRX	OptimizeRx Corp	FEBBO WILLIAM J	CHIEF EXECUTIVE OFF ...	Buy	P	10.50	1,000	10,500	15,667	14.7 K to 15.7 K (+6.82 %)
Jun 18 2018	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Buy	P	8.11	1,600	12,976	7,897	6.3 K to 7.9 K (+25.41 %)
Jun 18 2018	OPRX	OptimizeRx Corp	Paramore Miriam J	PRESIDENT	Buy	P	8.05	3,400	27,370	6,297	2.9 K to 6.3 K (+117.36 %)

Page: 1 2 next >